Tibaldi, C., Lunghi, A., & Baldini, E. (2017). Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors. World J Clin Oncol.
Citação norma ChicagoTibaldi, Carmelo, Alice Lunghi, and Editta Baldini. "Use of Programmed Cell Death Protein Ligand 1 Assay to Predict the Outcomes of Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors." World J Clin Oncol 2017.
Citação norma MLATibaldi, Carmelo, Alice Lunghi, and Editta Baldini. "Use of Programmed Cell Death Protein Ligand 1 Assay to Predict the Outcomes of Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors." World J Clin Oncol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.